ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphere®, announces the completion of its acquisition of Amplexor Life Sciences. This deal will deliver the most intelligent, connected, and comprehensive regulatory platform available, bringing increased efficiency for life sciences organizations as they bring new therapies to market. A key development is the introduction of LifeSphere Quality Management, marking ArisGlobal’s entry into the continuous quality improvement and risk management aspects of drug development.
Read the full article: Drug Development Technology Leader ArisGlobal Completes Acquisition of Amplexor Life Sciences //
Source: https://www.prnewswire.com/news-releases/drug-development-technology-leader-arisglobal-completes-acquisition-of-amplexor-life-sciences-301802368.html